Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions.
Reduced natural killer cell activity was observed in patients with oral leukoplakia and submucous fibrosis compared with normal control subjects. However, the number of target binding lymphocytes was found to be normal in these precancers. Treatment of effector cells with interferon-alpha resulted in highly elevated active killer cell activity, although no change was observed in target binding lymphocyte counts. This finding could imply that precytotoxic cells that are activated by interferon exist in peripheral blood or that direct recruitment of a new cell population takes place. In addition, altered target lysis kinetics was observed, with interferon-activated killer cells demonstrating a tremendous lytic activation that is completed so quickly that a statistical kinetic analysis could not be accurately done. Because natural killer cell activity is an important effector system in immunosurveillance against tumors, its modulation with interferon may be an exciting clinical possibility in the control of malignant transformation or oral precancers.
Division of Immunology, Regional Cancer Centre, Trivandrum, India.
M R
MR
Pillai
P
P
Balaram
S
S
Kannan
L
L
Sudha
K R
KR
Nalinakumari
N K
NK
Hareendran
M K
MK
Nair
D000704:Analysis of Variance; D002453:Cell Cycle; D002471:Cell Transformation, Neoplastic; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D007372:Interferons / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000276:immunology*; D004915:Leukemia, Erythroblastic, Acute / Q000276:immunology; D007972:Leukoplakia, Oral / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D015166:Monitoring, Immunologic; D009914:Oral Submucous Fibrosis / Q000276:immunology*
D007370:Interferon Type I; D007372:Interferons